German firm Merck KGaA to acquire RTP-based SpringWorks for $3.9B
Merck KGaA will acquire SpringWorks Therapeutics, a biotech firm with operations in Research Triangle Park, in a $3.9 billion cash deal. SpringWorks, which recently secured FDA app…
Merck KGaA will acquire SpringWorks Therapeutics, a biotech firm with operations in Research Triangle Park, in a $3.9 billion cash deal. SpringWorks, which recently secured FDA app…